Search Results - "COOKFAIR, D. L"

Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis by RUDICK, R. A, SIMONIAN, N. A, MASS, M. K, RICHERT, J. R, SALAZAR, A. M, MUNSCHBAUER, F. E, COOKFAIR, D. L, SIMON, J. H, JACOBS, L. D, ALAM, J. A, CAMPION, M, SCARAMUCCI, J. O, JONES, W, COATS, M. E, GOODKIN, D. E, WEINSTOCK-GUTTMAN, B, HERNDON, R. M

Get full text

Development of a multiple sclerosis functional composite as a clinical trial outcome measure by Cutter, Gary R., Baier, Monika L., Rudick, Richard A., Cookfair, Diane L., Fischer, Jill S., Petkau, John, Syndulko, Karl, Weinshenker, Brian G., Antel, Jack P., Confavreux, Christian, Ellison, George W., Lublin, Fred, Miller, Aaron E., Rao, Stephen M., Reingold, Stephen, Thompson, Alan, Willoughby, Ernest

“…The primary clinical outcome measure for evaluating multiple sclerosis in clinical trials has been Kurtzke's expanded disability status scale (EDSS). New…”
Get full text

Semi-automatic brain region extraction (SABRE) reveals superior cortical and deep gray matter atrophy in MS by Carone, D.A., Benedict, R.H.B., Dwyer, M.G., Cookfair, D.L., Srinivasaraghavan, B., Tjoa, C.W., Zivadinov, R.

“…In multiple sclerosis (MS), atrophy occurs in various cortical and subcortical regions. However, it is unclear whether this is mostly due to gray (GM) or white…”
Get full text

A longitudinal study of brain atrophy in relapsing multiple sclerosis by SIMON, J. H, JACOBS, L. D, SIMONIAN, N, LAJAUNIE, M, MILLER, D. E, WENDE, K, MARTENS-DAVIDSON, A, KINKEL, R. P, MUNSCHAUER, F. E, BROWNSCHEIDLE, C. M, CAMPION, M. K, RUDICK, R. A, COOKFAIR, D. L, HERNDON, R. M, RICHERT, J. R, SALAZAR, A. M, FISCHER, J. S, GOODKIN, D. E

Get full text

Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis by RUDICK, R. A, GOODKIN, D. E, ALAM, J. J, SIMONIAN, N. A, CAMPION, M. K, BARTOSZAK, D. M, BOURDETTE, D. N, BRAIMAN, J, BROWNSCHEIDLE, C. M, COATS, M. E, COHAN, S. L, DOUGHERTY, D. S, JACOBS, L. D, KINKEL, R. P, MASS, M. K, MUNSCHAUER, F. E, PRIORE, R. L, PULLICINO, P. M, SCHEROKMAN, B. J, WEISTOCK-GUTTMAN, B, WHITHAM, R. H, COOKFAIR, D. L, HERNDON, R. M, RICHERT, J. R, SALAZAR, A. M, FISCHER, J. S, GRANGER, C. V, SIMON, J. H

Get full text

In vitro and in vivo inhibition of mitogen-driven T-cell activation by recombinant interferon beta by RUDICK, R. A, CARPENTER, C. S, COOKFAIR, D. L, TUOHY, V. K, RANSOHOFF, R. M

“…Recombinant interferon beta (rIFN beta) is being tested as experimental immunotherapy for exacerbating-remitting MS. To clarify the possible mechanisms of a…”
Get full text

Radiation dose and leukemia risk in patients treated for cancer of the cervix by Boice, Jr, J D, Blettner, M, Kleinerman, R A, Stovall, M, Moloney, W C, Engholm, G, Austin, D F, Bosch, A, Cookfair, D L, Krementz, E T, Latourette, H B, Peters, L J, Schulz, M D, Lundell, M, Pettersson, F, Storm, H H, Bell, C M, Coleman, M P, Fraser, P, Palmer, M, Prior, P, Choi, N W, Hislop, T G, Koch, M, Robb, D, Robson, D, Spengler, R F, von Fournier, D, Frischkorn, R, Lochmüller, H, Pompe-Kirn, V, Rimpela, A, Kjørstad, K, Pejovic, M H, Sigurdsson, K, Pisani, P, Kucera, H, Hutchison, G B

“…To quantify the risk of radiation-induced leukemia and provide further information on the nature of the relationship between dose and response, a case-control…”
Get more information

Leukemia, Lymphoma, and Multiple Myeloma after Pelvic Radiotherapy for Benign Disease by Inskip, Peter D., Kleinerman, Ruth A., Stovall, Marilyn, Cookfair, Diane L., Hadjimichael, Olympia, Moloney, William C., Monson, Richard R., Thompson, W. Douglas, Wactawski-Wende, Jean, Wagoner, Joseph K., Boice, John D.

“…The relationship between exposure to sparsely ionizing radiation and mortality due to cancers of hematopoietic and lymphopoietic tissues was studied among…”
Get full text

A longitudinal study of T1 hypointense lesions in relapsing MS : MSCRG trial of interferon β-1a by SIMON, J. H, LULL, J, MCCABE, K, SERRA, A, CAMPION, M. K, FISCHER, J. S, GOODKIN, D. E, SIMONIAN, N, LAJAUNIE, M, WENDE, K, MARTENS-DAVIDSON, A, KINKEL, R. P, JACOBS, L. D, MUNSCHAUER, F. E, RUDICK, R. A, COOKFAIR, D. L, HERNDON, R. M, RICHERT, J. R, SALAZAR, A. M, SHEEDER, J, MILLER, D

Get full text

Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis: Multiple sclerosis by RUDICK, R. A, GOODKIN, D. E, ALAM, J. J, SIMONIAN, N. A, CAMPION, M. K, BARTOSZAK, D. M, BOURDETTE, D. N, BRAIMAN, J, BROWNSCHEIDLE, C. M, COATS, M. E, COHAN, S. L, DOUGHERTY, D. S, JACOBS, L. D, KINKEL, R. P, MASS, M. K, MUNSCHAUER, F. E, PRIORE, R. L, PULLICINO, P. M, SCHEROKMAN, B. J, WEISTOCK-GUTTMAN, B, WHITHAM, R. H, COOKFAIR, D. L, HERNDON, R. M, RICHERT, J. R, SALAZAR, A. M, FISCHER, J. S, GRANGER, C. V, SIMON, J. H

Get full text

Intrauterine growth retardation and risk of sudden infant death syndrome (SIDS) by Buck, G M, Cookfair, D L, Michalek, A M, Nasca, P C, Standfast, S J, Sever, L E, Kramer, A A

“…The purpose of this study was to assess whether intrauterine growth retardation was associated with an increased risk of sudden infant death syndrome (SIDS). A…”
Get more information

Chromosome Aberrations in Lymphocytes from Women Irradiated for Benign and Malignant Gynecological Disease by Kleinerman, Ruth A., Littlefield, L. Gayle, Tarone, Robert E., Sayer, Anne M., Cookfair, Diane L., Wactawski-Wende, Jean, Inskip, Peter D., Block, AnneMarie W., Ramesh, K. H., Boice, John D.

“…Excess leukemias have occurred after partial-body radiotherapy for cervical cancer and benign gynecological disease (BGD). However, the level of risk is nearly…”
Get full text

A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics of patients. Multiple Sclerosis Collaborative Research Group (MSCRG) by Jacobs, L D, Cookfair, D L, Rudick, R A, Herndon, R M, Richert, J R, Salazar, A M, Fischer, J S, Goodkin, D E, Granger, C V, Simon, J H

“…The design and conduct of a randomized, double-blinded, placebo-controlled, multicenter, phase III study of recombinant interferon beta-1a (IFN-beta-1a) as…”
Get more information

Timing of prenatal care and risk of sudden infant death syndrome by Buck, G M, Cookfair, D L, Michalek, A M, Nasca, P C, Standfast, S J, Sever, L E

“…Sudden infant death syndrome (SIDS) is the leading cause of death during post-neonatal life. Mothers whose infants succumb to SIDS are reported to initiate…”
Get more information

The quality of life in patients with cancer. A survey at one treatment center by Mettlin, C, Cookfair, D L, Lane, W, Pickren, J

Get more information

Mortality of a municipal worker cohort: II. Females by Vena, J E, Cookfair, D L, Fiedler, R C, Barnes, R E

“…Women have become an increasingly important segment of the total work force, yet there are very few published occupational mortality studies of female workers…”
Get more information

The use of goal attainment scaling to evaluate a cancer research training program for high school and college students by Cookfair, D L, Zevon, M A, Mirand, E A

“…Goal attainment scaling has been used frequently in the evaluation of mental health services. The purpose of this study was to assess the usefulness of the…”
Get more information

Interferons in relapsing remiting multiple sclerosis by Rudick, R A, Cookfair, D L, Griffin, J, Hauser, S, Piantadosi, S

Get full text

Quality of life among cancer patients by Cookfair, D L, Mettlin, C, Cummings, K M, Lane, W

Get more information

Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. 1997 by Rudick, R A, Goodkin, D E, Jacobs, L D, Cookfair, D L, Herndon, R M, Richert, J R, Salazar, A M, Fischer, J S, Granger, C V, Simon, J H, Alam, J J, Simonian, N A, Campion, M K, Bartoszak, D M, Bourdette, D N, Braiman, J, Brownscheidle, C M, Coats, M E, Cohan, S L, Dougherty, D S, Kinkel, R P, Mass, M K, Munschauer, F E, Priore, R L, Pullicino, P M, Scherokman, B J, Weistock-Guttman, B, Whitham, R H

Get full text